SUVENPHAR.BOSUVENPHAR.BOBSE
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+35.8%
5Y CAGR+29.8%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+35.8%/yr
Annual compound
5Y CAGR
+29.8%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.7x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$2.56B+83.6%
2024$1.40B+14.6%
2023$1.22B+18.9%
2022$1.02B+30.5%
2021$784.18M+12.8%
2020$695.06M-14.6%
2019$814.22M-